ferric compounds

Summary

Summary: Inorganic or organic compounds containing trivalent iron.

Top Publications

  1. ncbi Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
    Ajay Kumar Gupta
    Crusade Laboratories Limited, Southern General Hospital, 1345 Govan Road, Glasgow G51 4TF, Scotland, UK
    Biomaterials 26:3995-4021. 2005
  2. ncbi Intravenous iron administration in a short-stay hospital setting
    George Peebles
    Department of Renal Medicine, Sunderland Royal Hospital, Sunderland
    Nurs Stand 22:35-41. 2008
  3. ncbi Iron oxide nanoparticles for sustained delivery of anticancer agents
    Tapan K Jain
    Department of Pharmaceutical Sciences, College of Pharmacy, Nebraska Medical Center, Omaha, Nebraska 68198-6025, USA
    Mol Pharm 2:194-205. 2005
  4. ncbi An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure
    Morteza Mahmoudi
    Institute for Nanoscience and Nanotechnology, Sharif University of Technology, Tehran, Iran
    Nanotechnology 20:225104. 2009
  5. ncbi Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
    Jae Hyun Lee
    Department of Chemistry and Nanomedical National Core Research Center, Yonsei University, Seoul 120 749, Korea
    Nat Med 13:95-9. 2007
  6. ncbi EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma
    Costas G Hadjipanayis
    Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Cancer Res 70:6303-12. 2010
  7. ncbi Hypersensitivity reactions and deaths associated with intravenous iron preparations
    George R Bailie
    Albany Nephrology Pharmacy ANephRx Group, Albany, NY, USA
    Nephrol Dial Transplant 20:1443-9. 2005
  8. ncbi Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition
    Andrea Gojova
    Department of Mechanical and Aeronautical Engineering, University of California, Davis, Davis, California, USA
    Environ Health Perspect 115:403-9. 2007
  9. ncbi Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
    Xiang Hong Peng
    Department of Medical Oncology Hematology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Int J Nanomedicine 3:311-21. 2008
  10. ncbi Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution
    C Chouly
    Laboratoire de Biophysique, Faculte de Medecine, Angers, France
    J Microencapsul 13:245-55. 1996

Research Grants

  1. Biomimetic Studies of NO-binding Respiratory Chain Hemes
    JAMES COLLMAN; Fiscal Year: 2007
  2. Quantitative Subharmonic Breast Imaging
    Flemming Forsberg; Fiscal Year: 2010
  3. Hypertension in Hemodialysis Patients
    Rajiv Agarwal; Fiscal Year: 2007
  4. Hypertension in Hemodialysis Patients
    Rajiv Agarwal; Fiscal Year: 2010
  5. Pathobiology of Kidney Disease: Role of Iron
    Rajiv Agarwal; Fiscal Year: 2007
  6. Response to Iron Treatment for Restless Leg Syndrome
    Christopher Earley; Fiscal Year: 2004
  7. DOPAMINERGIC FUNCTION IN RESTLESS LEGS SYNDROME
    Christopher Earley; Fiscal Year: 2001
  8. Dopamine and Iron in Restless Legs Syndrome
    Christopher Earley; Fiscal Year: 2006
  9. Chronic Renal Insufficiency in NAPRTCS Patients
    Bradley Warady; Fiscal Year: 2007
  10. Effect of Age on Vein Graft Neointimal Formation
    Brian Cooley; Fiscal Year: 2003

Detail Information

Publications227 found, 100 shown here

  1. ncbi Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
    Ajay Kumar Gupta
    Crusade Laboratories Limited, Southern General Hospital, 1345 Govan Road, Glasgow G51 4TF, Scotland, UK
    Biomaterials 26:3995-4021. 2005
    ..This review discusses the synthetic chemistry, fluid stabilization and surface modification of superparamagnetic iron oxide nanoparticles, as well as their use for above biomedical applications...
  2. ncbi Intravenous iron administration in a short-stay hospital setting
    George Peebles
    Department of Renal Medicine, Sunderland Royal Hospital, Sunderland
    Nurs Stand 22:35-41. 2008
    ..In this arena the role of intravenous (IV) iron is well established. This article describes how IV iron may be given in total doses in a short-stay hospital setting...
  3. ncbi Iron oxide nanoparticles for sustained delivery of anticancer agents
    Tapan K Jain
    Department of Pharmaceutical Sciences, College of Pharmacy, Nebraska Medical Center, Omaha, Nebraska 68198-6025, USA
    Mol Pharm 2:194-205. 2005
    ..This nanoparticle formulation can be used as a universal drug carrier system for systemic administration of water-insoluble drugs while simultaneously allowing magnetic targeting and/or imaging...
  4. ncbi An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: a new toxicity identification procedure
    Morteza Mahmoudi
    Institute for Nanoscience and Nanotechnology, Sharif University of Technology, Tehran, Iran
    Nanotechnology 20:225104. 2009
    ..It is shown that a more reliable way of identifying cytotoxicity for in vitro assessments is to use particles with saturated surfaces via interactions with DMEM before usage...
  5. ncbi Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
    Jae Hyun Lee
    Department of Chemistry and Nanomedical National Core Research Center, Yonsei University, Seoul 120 749, Korea
    Nat Med 13:95-9. 2007
    ..Also, we successfully visualized small tumors implanted in a mouse. Such high-performance, nanotechnology-based molecular probes could enhance the ability to visualize other biological events critical to diagnostics and therapeutics...
  6. ncbi EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma
    Costas G Hadjipanayis
    Brain Tumor Nanotechnology Laboratory, Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA
    Cancer Res 70:6303-12. 2010
    ....
  7. ncbi Hypersensitivity reactions and deaths associated with intravenous iron preparations
    George R Bailie
    Albany Nephrology Pharmacy ANephRx Group, Albany, NY, USA
    Nephrol Dial Transplant 20:1443-9. 2005
    ..We used the US Food and Drug Administration's Freedom of Information (FOI) surveillance database to compare the type 1 AE profiles for the three intravenous iron preparations available in the United States...
  8. ncbi Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition
    Andrea Gojova
    Department of Mechanical and Aeronautical Engineering, University of California, Davis, Davis, California, USA
    Environ Health Perspect 115:403-9. 2007
    ..Ultrafine particles appear to cross the pulmonary epithelial barrier into the bloodstream, raising the possibility of direct contact with the vascular endothelium...
  9. ncbi Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
    Xiang Hong Peng
    Department of Medical Oncology Hematology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Int J Nanomedicine 3:311-21. 2008
    ..We review recent advances in the development of targeted IO nanoparticles for tumor imaging and therapy...
  10. ncbi Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution
    C Chouly
    Laboratoire de Biophysique, Faculte de Medecine, Angers, France
    J Microencapsul 13:245-55. 1996
    ..It was up to 3 X lower for electrically neutral particles than for charged particles. Coated particles presented higher vascular persistence. The diagnostic potential for liver, lymph node or vascular imaging were discussed...
  11. ncbi A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial
    Stefanie Kulnigg
    Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
    Am J Gastroenterol 103:1182-92. 2008
    ....
  12. ncbi The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance
    Xuemei Wang
    State Key Lab of Bioelectronics, Chien Shiung WU Laboratory, Southeast University, Nanjing 210096, People s Republic of China
    J Biomed Mater Res A 80:852-60. 2007
    ....
  13. ncbi Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling
    Michal Babic
    Institute of Macromolecular Chemistry, v v i, Academy of Sciences of the Czech Republic, Heyrovsky Sq 2, 162 06 Prague 6, Czech Republic
    Bioconjug Chem 19:740-50. 2008
    ..In comparison with Endorem, nanoparticles modified with PLL of an optimum molecular weight demonstrated a higher efficiency of intracellular uptake by MSC cells...
  14. ncbi Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents
    Volker Mailänder
    Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Institute of Transfusion Medicine, University of Ulm, Helmholtzstr 10, 89081 Ulm, Germany
    Mol Imaging Biol 10:138-46. 2008
    ..A steady increase in uptake of nanoparticles was detected with a higher density of carboxyl groups showing the relevance of charged groups as in the case of Resovist. Aggregation of these polymeric nanoparticles was not found...
  15. ncbi Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial
    David B Van Wyck
    Arizona Health Sciences Center, University of Arizona College of Medicine, 1821 East Elm Street, Tucson, AZ 85719, USA
    Obstet Gynecol 110:267-78. 2007
    ..To estimate efficacy of rapid, large-dose intravenous (IV) administration of ferric carboxymaltose compared with oral iron therapy in anemic postpartum women...
  16. ncbi Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour
    E Farrell
    Department of Orthopaedics, Erasmus University Medical Centre, Rotterdam, Netherlands
    Osteoarthritis Cartilage 17:961-7. 2009
    ..It is non-radioactive, does not require viral transfection and is already approved for clinical use as a contrast agent...
  17. ncbi Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
    David B Van Wyck
    DaVita, Inc, Tucson, Arizona, USA
    Transfusion 49:2719-28. 2009
    ..The objective was to evaluate efficacy and safety of rapid, large-dose intravenous (IV) administration of ferric carboxymaltose compared to oral iron in correcting iron deficiency anemia due to heavy uterine bleeding...
  18. ncbi Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression
    Qiu sha Tang
    School of Clinical Medical Science, Southeast University, Nanjing 210009, China
    Biomaterials 29:2673-9. 2008
    ..This novel system made use of the relative low Curie point of MZF-NPs to control the in vivo hyperthermia temperature and therefore acquired safe and effective heat-inducible transgene expression...
  19. ncbi Catechol derivatives-coated Fe3O4 and gamma-Fe2O3 nanoparticles as potential MRI contrast agents
    H Basti
    ITODYS, Université Paris 7 CNRS UMR 7086, 15, rue Jean Antoine de Baif, 75205 Paris Cedex 13, France
    J Colloid Interface Sci 341:248-54. 2010
    ....
  20. ncbi In vivo MRI cell tracking: clinical studies
    Jeff W M Bulte
    Russell H Morgan Department of Radiology, Division of MR Research, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    AJR Am J Roentgenol 193:314-25. 2009
    ..The purpose of this review is to describe the principles of MRI cell tracking with superparamagnetic iron oxides and the four clinical trials that have been performed...
  21. ncbi Antioxidant activities and phenolic contents of the methanol extracts of the stems of Acokanthera oppositifolia and Adenia gummifera
    Adeolu A Adedapo
    Department of Veterinary Physiology, Biochemistry and Pharmacology, University of Ibadan, Ibadan, Nigeria
    BMC Complement Altern Med 8:54. 2008
    ..Antioxidants thus play an important role of protecting the human body against damage by the free radicals. Plants containing phenolic compounds have been reported to possess strong antioxidant properties...
  22. ncbi MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO
    Raoul D Oude Engberink
    Image Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands
    J Cereb Blood Flow Metab 28:841-51. 2008
    ..The use of SPIO-labeled monocytes provides a better tool to specifically assess the time window of monocyte infiltration...
  23. ncbi Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
    Stephan Metz
    Department of Diagnostic Radiology, Technical University Munich, Munich, Germany
    Eur Radiol 14:1851-8. 2004
    ..In vitro labeling of human monocytes for MR imaging is most effectively obtained with the approved SPIO Ferucarbotran. Potential subsequent in vivo cell tracking applications comprise, e.g. specific targeting of inflammatory processes...
  24. ncbi Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner
    Chunfu Zhang
    Junior Group Molecular Imaging, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
    Cancer Res 67:1555-62. 2007
    ..Furthermore, these molecular MR imaging probes are capable of distinguishing tumors differing in the degree of alpha(v)beta(3) integrin expression and in their angiogenesis profile even when using a clinical 1.5-T MR scanner...
  25. ncbi Respiration of metal (hydr)oxides by Shewanella and Geobacter: a key role for multihaem c-type cytochromes
    Liang Shi
    Pacific Northwest National Laboratory, Richland, Washington 99354, USA
    Mol Microbiol 65:12-20. 2007
    ..Thus, multihaem c-Cyts play critical roles in S. oneidensis MR-1- and G. sulfurreducens-mediated dissimilatory reduction of solid metal (hydr)oxides by facilitating ET across the bacterial cell envelope...
  26. ncbi Iron supplementation in pregnancy--does the preparation matter?
    Nir Melamed
    Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tiqwa, 49100, Israel
    Arch Gynecol Obstet 276:601-4. 2007
    ..To assess the use, side effects and discontinuation rates of iron preparations during pregnancy...
  27. ncbi Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field
    Sarah W Kamau
    Institute of Veterinary Biochemistry and Molecular Biology, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
    Nucleic Acids Res 34:e40. 2006
    ..The highly efficient gene transfer already within 5 min shows that this technique is a powerful tool for future in vivo studies, where rapid gene delivery is required before systemic clearance or filtration of the gene vectors occurs...
  28. ncbi Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging
    Jian Lu
    National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China
    Biomaterials 30:2919-28. 2009
    ..This sensitive MRI contrast agent may find applications in identification of small liver lesions, evaluation of the degree of liver cirrhosis, and differential diagnosis of other liver diseases...
  29. ncbi Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting
    Ji Ho Park
    Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093, USA
    Small 5:694-700. 2009
    ..It is concluded that the blood half-life of a targeting molecule-nanomaterial ensemble is a key consideration when selecting the appropriate ligand and nanoparticle chemistry for tumor targeting...
  30. ncbi Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging
    Chunfu Zhang
    Junior Group Molecular Imaging and Departments of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany
    Langmuir 23:1427-34. 2007
    ..This suggests silica-coated USPIO particles are most suited for cell labeling approaches in MRI...
  31. ncbi Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets
    Meike Schwarz
    Department of Cardiology, University of Freiburg, Freiburg, Germany
    Circ Res 99:25-33. 2006
    ..In conclusion, activation-specific GPIIb/IIIa blockade via human single-chain antibodies represents a promising novel strategy for antiplatelet therapy...
  32. ncbi Update on adverse drug events associated with parenteral iron
    Glenn M Chertow
    Department of Medicine, University of California San Francisco, UCSF Laurel Heights Suite 430, 3333 California Street, San Francisco, CA 94118 1211, USA
    Nephrol Dial Transplant 21:378-82. 2006
    ..Since that time, iron sucrose has become widely available and clinicians have gained additional experience with sodium ferric gluconate complex...
  33. ncbi Characterization of the ferrioxamine uptake system of Nitrosomonas europaea
    Xueming Wei
    Department of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331 2902, USA
    Microbiology 153:3963-72. 2007
    ..For efficient acquisition of Fe-loaded ferrioxamine, N. europaea needs both ferrioxamine transporters FoxA(1) and FoxA(2). FoxA(1) probably regulates its own production, and it controls the production of FoxA(2) as well...
  34. ncbi Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study
    Oliver Schroder
    First Department of Internal Medicine, Division of Gastroenterology, ZAFES, Johann Wolfgang Goethe University, Frankfurt, Germany
    Am J Gastroenterol 100:2503-9. 2005
    ..We therefore evaluated the efficacy and safety of intravenous iron sucrose as compared with oral iron sulfate for the treatment of iron deficiency anemia (IDA) in patients with IBD...
  35. ncbi A randomized controlled trial of oral versus intravenous iron in chronic kidney disease
    Rajiv Agarwal
    Indiana University School of Medicine, Richard L Roudebush VA Medical Center, Indianapolis, IN 46202, USA
    Am J Nephrol 26:445-54. 2006
    ..We conducted a randomized multicenter controlled trial in adult anemic, iron-deficient non-dialysis CKD (ND-CKD) patients (>or=stage 3) not receiving erythropoiesis-stimulating agents (ESAs)...
  36. ncbi Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
    James B Post
    Division of Nephrology, Lenox Hill Hospital, 100 East 77th Street, New York, NY 10021, USA
    Int Urol Nephrol 38:719-23. 2006
    ..Replenishing iron stores in anemic patients with chronic kidney disease significantly increases hemoglobin levels and should be considered as an integral part of the therapy for treating anemia in the predialysis population...
  37. ncbi In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection
    Xu hong Jing
    Center of Joint Surgery, Southwest Hospital, The Third Military Medical University, Chongqing, China
    Joint Bone Spine 75:432-8. 2008
    ..5T-system following injection of engineered autologous MSCs into the knee joint cavity in rabbit articular cartilage defect models...
  38. ncbi High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q
    Ed X Wu
    Jockey Club MRI Engineering Centre and Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong SAR, People's Republic of China
    NMR Biomed 17:507-12. 2004
    ..Microvessel densities estimated from the Q-maps are found to be in reasonable accord with histologically determined values. A possible application of Q-maps is the assessment of angiogenic activity in tumors...
  39. ncbi Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study
    Yun Hwan Kim
    Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea
    Acta Haematol 121:37-41. 2009
    ....
  40. ncbi Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
    Baoan Chen
    Department of Hematology, The Affi liated Zhongda Hospital, Clinical Medical School, Southeast University, Nanjing, 210009 P R China
    Int J Nanomedicine 4:65-71. 2009
    ..Thus our in vitro data strongly suggests a potential clinical application of MNP(Fe(3)O(4)) and BrTet combination on CML...
  41. ncbi Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells
    Sandra T van Tiel
    Department of Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Contrast Media Mol Imaging 5:247-57. 2010
    ..Consequently, for each cell type separately an optimal protocol has to be established...
  42. ncbi Focused RF hyperthermia using magnetic fluids
    T Onur Tasci
    Department of Bioengineering, University of Utah, Salt Lake City, Utah 84112, USA
    Med Phys 36:1906-12. 2009
    ..6 to 0.2 cm3 verifying the focusing capability of the system. The authors believe that the studies conducted in this work show that MFH can be a much more effective method with better heat localization and focusing abilities...
  43. ncbi Receptor-targeted nanoparticles for in vivo imaging of breast cancer
    Lily Yang
    Department of Surgery and Winship Cancer Institute, Emory University School of Medicine, C 4088, 1365 C Clifton Road NE, Atlanta, GA 30322, USA
    Clin Cancer Res 15:4722-32. 2009
    ..Cell-surface receptor-targeted magnetic iron oxide nanoparticles provide molecular magnetic resonance imaging contrast agents for improving specificity of the detection of human cancer...
  44. ncbi In vivo MRI stem cell tracking requires balancing of detection limit and cell viability
    K Nohroudi
    Department of Anatomy I, University of Cologne, Cologne, Germany
    Cell Transplant 19:431-41. 2010
    ..Conclusively, though careful titration is indicated, MPIOs are a promising tool for in vivo cell tracking and evaluation of cell-based therapies...
  45. ncbi Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3,4-dihydroxyphenyl-l-alanine linkages
    Lei Zhang
    Department of Chemical Engineering, University of Washington, Box 351750, Seattle, WA 98195, United States
    Biomaterials 31:6582-8. 2010
    ....
  46. ncbi Use of parenteral iron products and serious anaphylactic-type reactions
    Diane K Wysowski
    Office of Surveillance and Epidemiology, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Am J Hematol 85:650-4. 2010
    ..To help differentiate risk among the parenteral iron products, the brand name of the product always should be provided on medical records, death certificates, and adverse drug reaction reports...
  47. ncbi Self-assembled simple hexagonal AB(2) binary nanocrystal superlattices: SEM, GISAXS, and defects
    Danielle K Smith
    Department of Chemical Engineering, Texas Materials Institute, Center for Nano and Molecular Science and Technology, The University of Texas at Austin, Austin, Texas 78712 1062, USA
    J Am Chem Soc 131:3281-90. 2009
    ..Additionally, nearly periodic superlattice dislocations consisting of inserted half-planes of gold nanocrystals were observed by SEM in some BSLs...
  48. ncbi Dissimilatory Fe(III) and Mn(IV) reduction
    Derek R Lovley
    Department of Microbiology, University of Massachusetts Amherst, Amherst, MA 01003, USA
    Adv Microb Physiol 49:219-86. 2004
    ..In comparison with other respiratory processes, the study of Fe(III) and Mn(IV) reduction is in its infancy, but genome-enabled approaches are rapidly advancing our understanding of this environmentally significant physiology...
  49. ncbi A human ferritin iron oxide nano-composite magnetic resonance contrast agent
    Masaki Uchida
    Department of Chemistry and Biochemistry, Montana State University, Bozeman, Montana 59715, USA
    Magn Reson Med 60:1073-81. 2008
    ..These results encourage further investigation into the development of the rHFn-iron oxide contrast agent to assess inflammatory disease status such as macrophage-rich atherosclerotic plaques in vivo...
  50. ncbi Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study
    Sebastien Boutry
    Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons Hainaut, Mons, Belgium
    Contrast Media Mol Imaging 3:223-32. 2008
    ..The viability of cells, estimated by methods assessing cell membrane permeability, was not affected by magnetic labeling in the conditions used in this work...
  51. ncbi Parenteral iron nephrotoxicity: potential mechanisms and consequences
    Richard A Zager
    Department of Medicine, University of Washington, Seattle, Washington, USA
    Kidney Int 66:144-56. 2004
    ..However, concerns of potential iron toxicity persist. Thus, this study was conducted to more fully gauge iron toxicologic profiles and potential determinants thereof...
  52. ncbi Incidence of side-effects associated with high-dose ferric gluconate in patients with severe chronic renal failure
    Bahar Bastani
    Division of Nephrology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA
    Nephrology (Carlton) 8:8-10. 2003
    ..In conclusion, Ferrlecit doses of 250 or 500 mg are complicated with significant untoward reactions in 10-30% of patients, in a dose-dependent fashion...
  53. ncbi A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin
    J Stoves
    Department of Nephrology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Nephrol Dial Transplant 16:967-74. 2001
    ..Where intravenous iron is preferred, lower doses may help to reduce the incidence of allergic or "free iron" reactions, especially in patients with low body mass...
  54. ncbi Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum
    M M Timmerman
    Department of Medical Microbiology and Immunology, Microbiology Doctoral Training Program, University of Wisconsin, Madison 53706, USA
    Infect Immun 69:7671-8. 2001
    ..and a potential role for the extracellular ferric reductase in utilization of environmental and host ferric compounds through the production of free, soluble Fe(II)...
  55. ncbi Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration
    Vaughn W Folkert
    Albert Einstein College of Medicine Montefiore Medical Center, Bronx, NY, USA
    Am J Kidney Dis 41:651-7. 2003
    ..Higher individual doses of SFGC would permit more rapid repletion of iron stores and greater flexibility in maintenance iron therapy as well as simplify treatment of peritoneal dialysis patients and chronic kidney disease patients...
  56. ncbi Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
    Baoan Chen
    Department of Hematology, Zhongda Hospital, Southeast University, Nanjing, 210009, PR China
    Int J Nanomedicine 4:73-8. 2009
    ..It is concluded that 5-BrTet and MNP-Fe(3)O(4) combined with DNR had a significant tumor-suppressing effect on a MDR leukemia cells xenograft model...
  57. ncbi Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium
    Yoram Amsalem
    Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer 52621, Israel
    Circulation 116:I38-45. 2007
    ..We sought to determine whether mesenchymal stem cell (MSC) outcome is affected by SPIO labeling in a rat model of myocardial infarction...
  58. ncbi Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging
    Martin Bendszus
    Department of Neuroradiology, University of Wurzburg, D 97080 Wurzburg, Germany
    J Neurosci 23:10892-6. 2003
    ..SPIO-enhanced MRI provides a new tool to selectively visualize active periods of macrophage transmigration into the nervous system, thus enabling dynamic views on a fundamental process in a multitude of nerve disorders...
  59. ncbi Electrically conductive bacterial nanowires produced by Shewanella oneidensis strain MR-1 and other microorganisms
    Yuri A Gorby
    Pacific Northwest National Laboratory, Richland, WA 99352, USA
    Proc Natl Acad Sci U S A 103:11358-63. 2006
    ....
  60. ncbi The use of superparamagnetic nanoparticles for prosthetic biofilm prevention
    Erik N Taylor
    Nanomedicine Laboratories, Division of Engineering, and Department of Orthopaedics, Brown University, Providence, RI 02912, USA
    Int J Nanomedicine 4:145-52. 2009
    ....
  61. ncbi Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy
    J H Liu
    Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
    Int J Clin Pract 63:387-93. 2009
    ..The relationship between antibodies to hepatitis B surface antigen (anti-HBsAg) responsiveness after hepatitis B vaccination and rHuEPO/adjuvant iron supplementation has not been reported before...
  62. ncbi Quantification of superparamagnetic iron oxide (SPIO)-labeled cells using MRI
    Ali M Rad
    Department of Radiology, Henry Ford Health System, Detroit, Michigan 48202, USA
    J Magn Reson Imaging 26:366-74. 2007
    ..To show the feasibility of using magnetic resonance imaging (MRI) to quantify superparamagnetic iron oxide (SPIO)-labeled cells...
  63. ncbi Oxidative decomposition of atrazine by a Fenton-like reaction in a H2O2/ferrihydrite system
    Juliana C Barreiro
    Departamento de Quimica, UFSCar, Rod Washington Luís SP 310, km 235, 13565 905 São Carlos SP, Brazil
    Water Res 41:55-62. 2007
    ..Three degradation products (desethylatrazine, desisopropylatrazine, and 2-hydroxyatrazine) were identified and corroborate with a Fenton reaction taking place in solution...
  64. ncbi Redox thermodynamics of the Fe(III)/Fe(II) couple of human myeloperoxidase in its high-spin and low-spin forms
    Gianantonio Battistuzzi
    Department of Chemistry, University of Modena and Reggio Emilia, Via Campi 183, 41100 Modena, Italy
    Biochemistry 45:12750-5. 2006
    ....
  65. ncbi Disruption of iron homeostasis increases phosphine toxicity in Caenorhabditis elegans
    Nicholas Valmas
    School of Molecular and Microbial Sciences, The University of Queensland, St Lucia, QLD 4072 Australia
    Toxicol Sci 96:194-201. 2007
    ..This study identifies similarities between phosphine toxicity and iron overload and demonstrates that phosphine can trigger iron release from storage proteins, increasing lipid peroxidation, leading to cell injury and/or cell death...
  66. ncbi Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents
    Danuta S Kalinowski
    Iron Metabolism and Chelation Program, Department of Pathology, University of Sydney, Sydney, New South Wales 2006, Australia
    J Med Chem 50:3716-29. 2007
    ..The increased ability of BpT-Fe complexes to catalyze ascorbate oxidation and benzoate hydroxylation, relative to their DpT and NBpT analogues, suggested that redox cycling plays an important role in their antiproliferative activity...
  67. ncbi Control of ferrous iron oxidation within circumneutral microbial iron mats by cellular activity and autocatalysis
    Jeremy A Rentz
    American Type Culture Collection, Manassas, Virginia 20109, USA
    Environ Sci Technol 41:6084-9. 2007
    ....
  68. ncbi Biogeochemistry and community composition of iron- and sulfur-precipitating microbial mats at the Chefren mud volcano (Nile Deep Sea Fan, Eastern Mediterranean)
    Enoma O Omoregie
    Max Planck Institute for Marine Microbiology, Bremen, Germany
    Appl Environ Microbiol 74:3198-215. 2008
    ..Both mats and the sediments underneath them hosted very diverse microbial communities and contained mineral precipitates, most likely due to differences in fluid flow patterns...
  69. ncbi Distinct reaction pathways followed upon reduction of oxy-heme oxygenase and oxy-myoglobin as characterized by Mössbauer spectroscopy
    Ricardo Garcia-Serres
    Department of Physics, Emory University, Atlanta, Georgia 30322, USA
    J Am Chem Soc 129:1402-12. 2007
    ..The fact that a ferryl intermediate does not accumulate in HO underscores the determining role played by protein structure in controlling the reactivity of reaction intermediates...
  70. ncbi Kinetics of reductive dissolution of hematite by bioreduced anthraquinone-2,6-disulfonate
    Chongxuan Liu
    Pacific Northwest National Laboratory, P O Box 999, MS K8 96, Richland, Washington 99352, USA
    Environ Sci Technol 41:7730-5. 2007
    ..The rates were also affected by the redox reaction free energy when reductive dissolution approached equilibrium. This study demonstrated the importance of the geochemical variables for the reductive dissolution kinetics of iron oxides...
  71. ncbi Arg97 at the heme-distal side of the isolated heme-bound PAS domain of a heme-based oxygen sensor from Escherichia coli (Ec DOS) plays critical roles in autoxidation and binding to gases, particularly O2
    Yukako Ishitsuka
    Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai 980 8577, Japan
    Biochemistry 47:8874-84. 2008
    ..Moreover, the binding behavior of cyanide to the Fe(III) complexes of the Arg mutant proteins was similar to that of O2, which is evident from the Kd values, suggestive of electrostatic interactions between cyanide and Arg97...
  72. ncbi Homogeneous iron-catalyzed photochemical degradation of muconic acid in water
    Eva Rodriguez
    Departamento de Ingenieria Quimica y Energetica, Universidad de Extremadura, Av Elvas s n, 06071 Badajoz, Spain
    Water Res 41:1325-33. 2007
    ....
  73. ncbi Iron autoxidation and free radical generation: effects of buffers, ligands, and chelators
    Kevin D Welch
    Biotechnology Center, Utah State University, Logan, Utah 84322-4705, USA
    Arch Biochem Biophys 397:360-9. 2002
    ..Ferrous iron was shown to be able to directly reduce some quinones without the reduction of oxygen. In conclusion, this study demonstrates the complexity of iron chemistry, especially the chelation of iron and its subsequent reactivity...
  74. ncbi Kinetics and mechanisms for reactions of Fe(II) with iron(III) oxides
    Byong Hun Jeon
    Department of Civil and Environmental Engineering, The Pennsylvania State University, 212 Sackett Building, University Park, Pennsylvania 16802 2450, USA
    Environ Sci Technol 37:3309-15. 2003
    ..The unique interactions of Fe(II) with iron(III) oxides would be environmentally important to understand the fate of redox-sensitive chemicals...
  75. ncbi Electrochemical studies of the mono-Fe, Fe-Zn, and Fe-Fe metalloisoforms of bacteriophage lambda protein phosphatase
    Tiffany A Reiter
    Section of Hematology Research and the Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Biochemistry 43:782-90. 2004
    ..These results suggest that the active site of lambdaPP supports a high oxidation potential for both metal sites and may indicate an equally oxidizing active site for other member metallophosphoesterases...
  76. ncbi Studies on the nature of interaction of iron(III) with alginates
    Kalarical Janardhanan Sreeram
    Chemical Laboratory, Central Leather Research Institute, Adyar, Chennai 600 020, India
    Biochim Biophys Acta 1670:121-5. 2004
    ..The number of binding sites per molecule of alginate has been estimated to be 66. This indicates that the alginate can bind more number of Fe(III) ions and thus provide a stable complex which can find wide industrial applications...
  77. ncbi X-ray crystal structure of Desulfovibrio vulgaris rubrerythrin with zinc substituted into the [Fe(SCys)4] site and alternative diiron site structures
    Shi Jin
    Department of Chemistry, Center for Metalloenzyme Studies, University of Georgia, Athens, Georgia 30602, USA
    Biochemistry 43:3204-13. 2004
    ....
  78. ncbi A structural and Mössbauer study of complexes with Fe(2)(micro-O(H))(2) cores: stepwise oxidation from Fe(II)(micro-OH)(2)Fe(II) through Fe(II)(micro-OH)(2)Fe(III) to Fe(III)(micro-O)(micro-OH)Fe(III)
    Audria Stubna
    Department of Chemistry, Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, Pennsylvania 15213, USA
    Inorg Chem 43:3067-79. 2004
    ..The resultant true shifts were analyzed in a two-state hopping model. The diferric complex 3 is antiferromagnetically coupled with J = 90 +/- 15 cm(-)(1), estimated from a variable-temperature Mössbauer analysis...
  79. ncbi Particulate arsenic and iron during anoxia in a eutrophic, urban lake
    David B Senn
    Exposure, Epidemiology, and Risk Program, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Environ Toxicol Chem 23:1610-6. 2004
    ..05 microm) against predictions by surface complexation modeling of As on amorphous Fe(III) oxides argue that arsenic sorbed on Fe(III) oxides was the major As species present in this lake's hypolimnion throughout several months of anoxia...
  80. ncbi Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases
    Mary H Bridge
    Institute of Applied Synthetic Chemistry, Vienna University of Technology, Getreidemarkt 9/163-AC, A-1060 Vienna, Austria
    Biochim Biophys Acta 1690:77-84. 2004
    ..Additional complexation titrations, pH ranging from 1 to 7, confirm a weak complexation reaction occurring between Fe(III) and nicotine...
  81. ncbi Glucose oxidase-magnetite nanoparticle bioconjugate for glucose sensing
    Liane M Rossi
    Department of Chemistry, Advanced Material Research Institute (AMRI, University of New Orleans, New Orleans, LA 70148, USA
    Anal Bioanal Chem 380:606-13. 2004
    ..Immobilization of glucose oxidase on the nanoparticles also increased the stability of the enzyme. When stored at 4 degrees C the nanoparticle suspensions maintained their bioactivity for up to 3 months...
  82. ncbi Reduction of aqueous chromate by Fe(II)/Fe(III) carbonate green rust: kinetic and mechanistic studies
    Ludovic Legrand
    Laboratoire Analyse et Environnement, UMR 8587 CNRS Université d Evry Val d Essonne CEA, Batiment des Sciences, 1 Rue du Père Jarland, 91025 Evry Cedex, France
    Environ Sci Technol 38:4587-95. 2004
    ..In the case of thick green rust particles resulting from the corrosion of iron in permeable reactive barriers, the quantity of FeII readily accessible for efficient CrVI removal should be rather low...
  83. ncbi The heme iron coordination of unfolded ferric and ferrous cytochrome c in neutral and acidic urea solutions. Spectroscopic and electrochemical studies
    Milan Fedurco
    Department of Chemistry, University of Geneva, 30 Quai Ernest Ansermet, CH 1211 Geneva, Switzerland
    Biochim Biophys Acta 1703:31-41. 2004
    ..8. The formal redox potential of the His/H(2)O complex of cytochrome c in 9 M urea at pH 3 was estimated to be -0.13 V, ca. 100 mV more positive than E degrees ' estimated for the bis-His complex of cytochrome c in urea solution at pH 7...
  84. ncbi Role of ceruloplasmin in macrophage iron efflux during hypoxia
    Joydeep Sarkar
    Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Biol Chem 278:44018-24. 2003
    ..Together these data show that Cp stimulates iron release from macrophages under hypoxic conditions by a ferroxidase-dependent mechanism, possibly involving generation of a negative iron gradient...
  85. ncbi Kinetics and structural constraints of chromate reduction by green rusts
    Deborah L Bond
    Department of Geological and Environmental Sciences, Stanford University, Stanford, California 94305-2115, USA
    Environ Sci Technol 37:2750-7. 2003
    ..The mole fraction of Fe(III) in the Cr(x),Fe(1-x)(OH)3 x nH2O reaction product ranged from 17% to 68%, leading to a highly stabilized (low solubility) phase...
  86. ncbi The role of iron and the factors affecting off-color development of polyphenols
    Renee I Mellican
    The Procter and Gamble Company, Miami Valley Laboratories, 11810 East Miami River Road, Cincinnati, Ohio 45252, USA
    J Agric Food Chem 51:2304-16. 2003
    ..Using the ferrous form of iron and maintaining it in its reduced form by lowering pH, removing oxygen, and including reducing agents, it was possible to fortify foods with highly bioavailable iron...
  87. ncbi Iron oxide surface-catalyzed oxidation of ferrous iron by monochloramine: implications of oxide type and carbonate on reactivity
    Peter J Vikesland
    Department of Civil and Environmental Engineering, The University of Iowa, Iowa City 52242, USA
    Environ Sci Technol 36:512-9. 2002
    ..The implications of these changes are then discussed in light of the variable oxide studies...
  88. ncbi Mathematical model of the oxidation of ferrous iron by a biofilm of Thiobacillus ferrooxidans
    M M Mesa
    Department of Chemical Engineering, Faculty of Sciences, University of Cadiz, 11510 Puerto Real, Cadiz, Spain
    Biotechnol Prog 18:679-85. 2002
    ..The model can also be considered as an expression for the erosion of microorganisms immobilized due to the agitation of the medium by aeration...
  89. ncbi Effect of Fe(III)-ligand properties on effectiveness of modified photo-Fenton processes
    R Aplin
    School of Civil and Environmental Engineering, The University of New South Wales, Australia
    Water Sci Technol 44:23-30. 2001
    ..The most important properties of the oxalate ligand in the UV/Fe oxalate/H2O2 process are that it forms Fe(III)-oxalato complexes that are easily photolysed and also is relatively unreactive with OH. radicals...
  90. ncbi Revisiting the metal-binding chemistry of nicotianamine and 2'-deoxymugineic acid. Implications for iron nutrition in strategy II plants
    Suzanne M Reichman
    Department of Environmental Sciences, University of California, Riverside, California 92521, USA
    Plant Physiol 129:1435-8. 2002
  91. ncbi Chemical aspects of siderophore mediated iron transport
    Hakim Boukhalfa
    Department of Chemistry, Duke University, Durham, NC 27708-0346, USA
    Biometals 15:325-39. 2002
    ..Specific emphasis is placed on a discussion of in vitro kinetic and thermodynamic data that are relevant to elucidating possible in vivo mechanisms for environmental iron acquisition by microbial cells...
  92. ncbi The iron oxidation and hydrolysis chemistry of Escherichia coli bacterioferritin
    X Yang
    Department of Chemistry, University of New Hampshire, Durham, New Hampshire 03824, USA
    Biochemistry 39:4915-23. 2000
    ..Iron oxidation is inhibited by the presence of Zn(2+) ions. The patterns of phase 2 and phase 3 inhibition are different, though inhibition of both phases is complete at 48 Zn(2+)per 24mer, i.e., 2 Zn(2+) per ferroxidase center...
  93. ncbi Arsenic mobility and groundwater extraction in Bangladesh
    Charles F Harvey
    Ralph M. Parsons Laboratory, Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 01239, USA
    Science 298:1602-6. 2002
    ....
  94. ncbi Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells
    Xi Huang
    Nelson Institute of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016 6451, USA
    Free Radic Biol Med 32:84-92. 2002
    ....
  95. ncbi Formation of ferrihydrite and associated iron corrosion products in permeable reactive barriers of zero-valent iron
    Yoko Furukawa
    Naval Research Laboratory, Seafloor Sciences Branch, Code 7431, Stennis Space Center, Mississippi 39529, USA
    Environ Sci Technol 36:5469-75. 2002
    ..The ubiquitous presence of ferrihydrite suggests that the use of Fe0-PRBs may be extended to applications that require contaminant adsorption rather than, or in addition to, redox-promoted contaminant degradation...
  96. ncbi Biochemistry. How iron activates O2
    Julie A Kovacs
    Department of Chemistry, University of Washington, Seattle, WA 98195, USA
    Science 299:1024-5. 2003
  97. ncbi Assembly of human frataxin is a mechanism for detoxifying redox-active iron
    HEATHER A O'NEILL
    Department of Pediatric Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Biochemistry 44:537-45. 2005
    ..In contrast, the assembled protein has ferroxidase activity and detoxifies redox-active iron by sequestering it in a protein-protected compartment...
  98. ncbi Degradation of azo dyes using low iron concentration of Fenton and Fenton-like system
    C L Hsueh
    Department of Chemical Engineering, National Cheng Kung University, Tainan City 701, Taiwan
    Chemosphere 58:1409-14. 2005
    ..High levels of H2O2 appear to reduce dye decolorization. In addition, it is also found that decolorization of azo dyes undergoes a faster reaction rate than mineralization of azo dyes...
  99. ncbi A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation
    Louise K Charkoudian
    Department of Chemistry, Duke University, P.O. Box 90346, Durham, North Carolina 27708, USA
    J Am Chem Soc 128:12424-5. 2006
    ..The pro-chelate approach of BSIH represents a promising strategy for chelating a specific pool of detrimental metal ions without disturbing healthy metal ion distribution...
  100. ncbi Decolorization kinetics of Procion H-exl dyes from textile dyeing using Fenton-like reactions
    K Ntampegliotis
    Department of Physical Sciences, Technological and Educational Institute of Larisa, Greece
    J Hazard Mater 136:75-84. 2006
    ..7 and 11.4 mg/l, respectively). The biodegradability, as expressed by the BOD/COD ratio, increases significantly from an initial value of 0.11-0.55 for the Fenton-like and to 0.72 for the photo-Fenton-like processes...
  101. ncbi Photo-assisted Fenton type processes for the degradation of phenol: a kinetic study
    Hrvoje Kusic
    University of Zagreb, Faculty of Chemical Engineering and Technology, Marulicev trg 19, HR 10000, Zagreb, Croatia
    J Hazard Mater 136:632-44. 2006
    ..Residual TOC by applied Fenton type processes ranged between 60.2 and 44.7%, while the efficiency of those processes was significantly enhanced in the presence of UV light, where residual TOC ranged between 15.2 and 2.4%...

Research Grants111 found, 100 shown here

  1. Biomimetic Studies of NO-binding Respiratory Chain Hemes
    JAMES COLLMAN; Fiscal Year: 2007
    ..An emphasis will be placed on kinetic and mechanistic studies to elucidate the putitive reaction pathways of CcO and NOR. ..
  2. Quantitative Subharmonic Breast Imaging
    Flemming Forsberg; Fiscal Year: 2010
    ....
  3. Hypertension in Hemodialysis Patients
    Rajiv Agarwal; Fiscal Year: 2007
    ..Evaluation of such strategies will improve BP control in hemodialysis patients and, in the long-term, provide cardiovascular protection. ..
  4. Hypertension in Hemodialysis Patients
    Rajiv Agarwal; Fiscal Year: 2010
    ..We hypothesize that that volume control can improve BP and antihypertensive therapy can regress left ventricular hypertrophy in long-term hemodialysis patients. ..
  5. Pathobiology of Kidney Disease: Role of Iron
    Rajiv Agarwal; Fiscal Year: 2007
    ..Novelty and Health Relatedness of the Project: This proposal will provide translational data on the role of intravenous iron to progression of kidney disease in patients with CKD. ..
  6. Response to Iron Treatment for Restless Leg Syndrome
    Christopher Earley; Fiscal Year: 2004
    ..An expected finding that IV iron reduces the brain iron insufficiency and dramatically reduces the RLS symptoms strongly supports our model of RLS caused by brain iron insufficiency. ..
  7. DOPAMINERGIC FUNCTION IN RESTLESS LEGS SYNDROME
    Christopher Earley; Fiscal Year: 2001
    ..The authors would also explore relationships between iron and CSF measures of dopaminergic activities, which could provide the basis for entirely new research and treatment approaches to RLS. ..
  8. Dopamine and Iron in Restless Legs Syndrome
    Christopher Earley; Fiscal Year: 2006
    ..Using CSF and MRI measurements of iron will assess the CNS iron status. RLS severity will be based on subjective (rating scale and diary) and objective (PSG) measurements. ..
  9. Chronic Renal Insufficiency in NAPRTCS Patients
    Bradley Warady; Fiscal Year: 2007
    ..abstract_text> ..
  10. Effect of Age on Vein Graft Neointimal Formation
    Brian Cooley; Fiscal Year: 2003
    ..Furthermore, the establishment of an age-associated model of vein grafting will permit age-specific evaluation of new therapeutic avenues for inhibiting neointimal formation. ..
  11. DETERMINING THE GENETICS OF RESTLESS LEGS SYNDROME
    Christopher Earley; Fiscal Year: 2003
    ....
  12. Low-Cost Digital Imaging System for Evaluating Thrombosis
    Brian Cooley; Fiscal Year: 2007
    ..This imaging methodology may have a capacity for future adaptation to clinical thrombosis imaging. ..
  13. ACUTE RENAL FAILURE--MECHANISMS AND ADAPTIVE RESPONSES
    RICHARD ZAGER; Fiscal Year: 2001
    ....
  14. FUNCTIONAL ANALOGUES OF 02 BINDING/ACTIVATING HEME SITES
    JAMES COLLMAN; Fiscal Year: 2001
    ..The role of distal steric effects and of H-bonding will be explored. The NO binding has relevance to many medical problems related to activation by the gaseous hormone, NO. Examples include vasodilation and neurotransmission. ..
  15. Acute Renal Failure: Mechanisms and Adaptive Responses
    RICHARD ZAGER; Fiscal Year: 2007
    ....
  16. Iron Therapy in Renal Disease: Potential Toxicities
    RICHARD ZAGER; Fiscal Year: 2007
    ..Potential reasons for these differences will be assessed, with the ultimate goal of defining the safest way of administering parenteral irons to renal disease patients. ..
  17. Functional active-site models of cytochrome c oxidase
    JAMES COLLMAN; Fiscal Year: 2007
    ..The role that the copper ion (CuB) and a phenolic group, in the amino acid tyrosine (Tyr244) play in the catalytic function of CcO are of particular interest. ..
  18. MODELS FOR CYTOCHROME P450 HYDROXYLASES
    JAMES COLLMAN; Fiscal Year: 1980
    ..To date, synthetic models for oxymyoglobin, deoxymyoglobin, and three states of cytochrome P-450 have been characterized. The vibrational frequency for coordinated dioxygen has been measured in both iron and cobalt porphyrin complexes...
  19. Subharmonic Microbubble Signals for Pressure Estimation
    Flemming Forsberg; Fiscal Year: 2007
    ..This will allow potentially life-threatening diseases, such as increased pressure in the liver, to be diagnosed early. ..
  20. ACUTE RENAL FAILURE--IMPACT OF FLUORINATED ANESTHETICS
    RICHARD ZAGER; Fiscal Year: 2001
    ....
  21. MR-Guided Delivery and Monitoring of Magnetocapsules Immunoprotecting Islet Cells
    JEFF BULTE; Fiscal Year: 2007
    ..As the MCs are composed of clinical grade and FDA-approved materials, this MR-guided approach will be readily translatable to human diabetic clinical trials for further improvements of islet cell transplantation. ..
  22. REGULATION OF HEPATIC HEME METABOLISM
    HERBERT BONKOVSKY; Fiscal Year: 2009
    ..the molecular mechanisms that mediate heme regulation of ALAS-1 and HO-1 are similar in avian, human, and murine hepatocytes in culture or in intact organisms. ..
  23. Developing MPI for Non-Invasive and Quantitative Imaging of Stem Cells
    JEFF BULTE; Fiscal Year: 2009
    ..If this new technique is developed successfully, it will help us to understand much better where the cells exactly go into the brain and elsewhere in the body, which will facilitate introducing these stem cells into patients. ..
  24. Functional active-site models of cytochrome c oxidase
    JAMES COLLMAN; Fiscal Year: 2009
    ..The role that the copper ion (CuB) and a phenolic group, in the amino acid tyrosine (Tyr244) play in the catalytic function of CcO are of particular interest. ..
  25. REGULATION OF HEPATIC HEME METABOLISM
    HERBERT BONKOVSKY; Fiscal Year: 1993
    ....
  26. REGULATION OF HEPATIC HEME METABOLISM
    HERBERT BONKOVSKY; Fiscal Year: 2006
    ..the molecular mechanisms that mediate heme regulation of ALAS-1 and HO-1 are similar in avian, human, and murine hepatocytes in culture or in intact organisms. ..
  27. MR Tracking of Magnetically Labeled Stem Cells in CNS
    JEFF BULTE; Fiscal Year: 2006
    ..abstract_text> ..
  28. REGULATIN OF HEPATIC HEME METABOLISM
    HERBERT BONKOVSKY; Fiscal Year: 2003
    ..abstract_text> ..
  29. Functional active-site models of cytochrome c oxidase
    JAMES COLLMAN; Fiscal Year: 2005
    ..The role that the copper ion (CuB) and a phenolic group, in the amino acid tyrosine (Tyr-244) play in the catalytic function of CcO are of particular interest. ..
  30. Nitroreductase: Determinants of Flavin Enzyme Activity
    Anne Frances Miller; Fiscal Year: 2004
    ..These tools will have widespread applicability to flavoproteins. ..
  31. ASN Workshop "In Vivo MR Tracking of Stem Cells in the CNS" (R13)
    JEFF BULTE; Fiscal Year: 2005
    ..The outcome of the workshop will be published in Experimental Neurology and available for the scientific community at large. ..